Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lanthio Pharma logo — Biopharmaceutical company discovering and developing stabili...

Lanthio Pharma

Biopharmaceutical company discovering and developing stabilized lanthipeptides in oncology and critical-care medicine

Founded 2010 The Netherlands The Netherlands 1 employees Debt Financing Total: $8.40M Biotechnology, Health and Wellness +1

General Information

Company Name Lanthio Pharma
Founded Year 2010
Location The Netherlands The Netherlands
Employees 1
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Lanthio Pharma. To contact Lanthio Pharma, visit lanthiopharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Lanthio Pharma

Lanthio Pharma is a Dutch biopharmaceutical company pioneering in the discovery and development of stabilized lanthipeptides for the treatment of severe diseases with high unmet medical needs. Founded in 2010, the company specializes in generating lanthionine-constrained peptides with superior target-selectivity and stability, leveraging its proprietary technologies. Lanthio Pharma's focus lies in building a robust pipeline of receptor-specific, stabilized lanthipeptides in the domains of oncology and critical-care medicine. The company's commitment to innovation and its potential to address critical medical requirements have garnered significant interest, as evidenced by its €3.60M Debt Financing investment on 21 May 2014. This investment stands as a testament to the confidence in Lanthio Pharma's novel approach and the prospects it holds for revolutionizing therapy in the biopharmaceutical industry.

Taxonomy: biopharmaceutical company, therapeutic peptides, oncology, critical-care medicine, drug discovery, proprietary technology, target-selectivity, stabilized peptides, medical research, clinical development, pharmaceutical innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing €3.60M -
21 May 2014
Series A €4.80M 2
BioGeneration Ventures Inkef
BioGeneration Ventures, Inkef
28 Nov 2012

Lanthio Pharma Alternatives & Competitors

Lanthio Pharma vs
Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc. United States

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge trea...

18 employees
Biopharma, Biotechnology
Lanthio Pharma vs
Sutura Therapeutics Ltd
Sutura Therapeutics Ltd United Kingdom

A biopharmaceutical company advancing biomolecular medicine through its drug conjugate platform.

4 employees
Biotechnology, Pharmaceutical
Lanthio Pharma vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care

FAQ About Lanthio Pharma

Biopharmaceutical company discovering and developing stabilized lanthipeptides in oncology and critical-care medicine
Lanthio Pharma was founded in 2010.
Lanthio Pharma is headquartered in The Netherlands.
Lanthio Pharma operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical company, therapeutic peptides, oncology and critical-care medicine.
Lanthio Pharma has approximately 1 employees.
Lanthio Pharma has completed 2 funding rounds, raising a total of $8.40M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Lanthio Pharma include Antharis Therapeutics, Inc., Sutura Therapeutics Ltd, Archimedes Pharma, AN2 Therapeutics, Day One Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lanthio Pharma and Antharis Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lanthio Pharma, https://bouncewatch.com/company/lanthio-pharma, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes